{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:57:17Z","timestamp":1790233037053,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,15]]},"DOI":"10.1097\/qai.0b013e31817ecb31","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:15:31Z","timestamp":1236269731000},"page":"511-521","source":"Crossref","is-referenced-by-count":15,"title":["In Vitro Characterization of Multidrug-Resistant HIV-1 Isolates From a Recently Infected Patient Associated With Dual Tropism and Rapid Disease Progression"],"prefix":"10.1097","volume":"48","author":[{"given":"Hiroshi","family":"Mohri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157016206775197628","article-title":"HIV-1 fitness and disease progression: insights from the SIV-Macaque model.","volume":"4","author":"Kimata","year":"2006","journal-title":"Curr HIV Res"},{"key":"R2-1-20210131","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.","volume":"273","author":"Dean","year":"1996","journal-title":"Science"},{"key":"R3-1-20210131","doi-asserted-by":"crossref","first-page":"978","DOI":"10.7326\/0003-4819-134-10-200105150-00012","article-title":"Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics.","volume":"134","author":"Hogan","year":"2001","journal-title":"Ann Intern Med"},{"key":"R4-1-20210131","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.med.54.101601.152346","article-title":"The influence of HLA genotype on AIDS.","volume":"54","author":"Carrington","year":"2003","journal-title":"Annu Rev Med"},{"key":"R5-1-20210131","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.181.4.1365","article-title":"Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.","volume":"181","author":"Klein","year":"1995","journal-title":"J Exp Med"},{"key":"R6-1-20210131","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199710303371803","article-title":"Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.","volume":"337","author":"Musey","year":"1997","journal-title":"N Engl J Med"},{"key":"R7-1-20210131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.","volume":"31","author":"Martin","year":"2002","journal-title":"Nat Genet"},{"key":"R8-1-20210131","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1126\/science.270.5238.988","article-title":"Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.","volume":"270","author":"Deacon","year":"1995","journal-title":"Science"},{"key":"R9-1-20210131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-118-9-199305010-00004","article-title":"Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.","volume":"118","author":"Koot","year":"1993","journal-title":"Ann Intern Med"},{"key":"R10-1-20210131","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1128\/JVI.74.19.9222-9233.2000","article-title":"A dual infection\/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.","volume":"74","author":"Quinones-Mateu","year":"2000","journal-title":"J Virol"},{"key":"R11-1-20210131","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(04)15596-7","article-title":"Dual HIV-1 infection associated with rapid disease progression.","volume":"363","author":"Gottlieb","year":"2004","journal-title":"Lancet"},{"key":"R12-1-20210131","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","article-title":"Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.","volume":"15","author":"Back","year":"1996","journal-title":"EMBO J"},{"key":"R13-1-20210131","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JVI.71.2.1089-1096.1997","article-title":"Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.","volume":"71","author":"Croteau","year":"1997","journal-title":"J Virol"},{"key":"R14-1-20210131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM199807303390504","article-title":"Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.","volume":"339","author":"Hecht","year":"1998","journal-title":"N Engl J Med"},{"key":"R15-1-20210131","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(98)12262-6","article-title":"Transmission of antiretroviral-drug-resistant HIV-1 variants.","volume":"354","author":"Yerly","year":"1999","journal-title":"Lancet"},{"key":"R16-1-20210131","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.282.12.1135","article-title":"HIV-1 drug resistance in newly infected individuals.","volume":"282","author":"Boden","year":"1999","journal-title":"JAMA"},{"key":"R17-1-20210131","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.282.12.1142","article-title":"Reduced antiretroviral drug susceptibility among patients with primary HIV infection.","volume":"282","author":"Little","year":"1999","journal-title":"JAMA"},{"key":"R18-1-20210131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0924-8579(00)00270-3","article-title":"Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study.","volume":"16","author":"Brenner","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"R19-1-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.288.2.181","article-title":"Time trends in primary HIV-1 drug resistance among recently infected persons.","volume":"288","author":"Grant","year":"2002","journal-title":"JAMA"},{"key":"R20-1-20210131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV.","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med"},{"key":"R21-1-20210131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.qai.0000219290.49152.6a","article-title":"Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience.","volume":"41","author":"Shet","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-1-20210131","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.","volume":"342","author":"Quinn","year":"2000","journal-title":"N Engl J Med"},{"key":"R23-1-20210131","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1128\/JVI.77.14.7736-7745.2003","article-title":"Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection.","volume":"77","author":"Simon","year":"2003","journal-title":"J Virol"},{"key":"R24-1-20210131","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/JVI.76.4.1753-1761.2002","article-title":"Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection.","volume":"76","author":"Brenner","year":"2002","journal-title":"J Virol"},{"key":"R25-1-20210131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(05)71139-9","article-title":"Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.","volume":"365","author":"Markowitz","year":"2005","journal-title":"Lancet"},{"key":"R26-1-20210131","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/JVI.67.4.1772-1777.1993","article-title":"Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.","volume":"67","author":"Connor","year":"1993","journal-title":"J Virol"},{"key":"R27-1-20210131","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1128\/JVI.68.7.4400-4408.1994","article-title":"Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.","volume":"68","author":"Connor","year":"1994","journal-title":"J Virol"},{"key":"R28-1-20210131","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/JVI.63.5.2118-2125.1989","article-title":"Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.","volume":"63","author":"Tersmette","year":"1989","journal-title":"J Virol"},{"key":"R29-1-20210131","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/374650","article-title":"Increased in vitro cytopathicity of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection.","volume":"187","author":"Kwa","year":"2003","journal-title":"J Infect Dis"},{"key":"R30-1-20210131","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.qai.0000173460.75322.93","article-title":"Enhanced replicative capacity and pathogenicity of HIV-1 isolated from individuals infected with drug-resistant virus and declining CD4+ T-cell counts.","volume":"40","author":"Solomon","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-1-20210131","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/aid.1993.9.541","article-title":"Biological cloning of functionally diverse quasispecies of HIV-1.","volume":"9","author":"Connor","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R32-1-20210131","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/AAC.44.4.920-928.2000","article-title":"A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.","volume":"44","author":"Petropoulos","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R33-1-20210131","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JVI.73.3.2343-2349.1999","article-title":"Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.","volume":"73","author":"Morner","year":"1999","journal-title":"J Virol"},{"key":"R34-1-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints.","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"R36-1-20210131","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1073\/pnas.96.10.5698","article-title":"A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.","volume":"96","author":"Baba","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-1-20210131","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-1-20210131","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/jm00002a019","article-title":"Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker.","volume":"38","author":"Bridger","year":"1995","journal-title":"J Med Chem"},{"key":"R39-1-20210131","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.38.4.668","article-title":"Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.","volume":"38","author":"De Clercq","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R40-1-20210131","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(86)90169-8","article-title":"Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.","volume":"2","author":"Asjo","year":"1986","journal-title":"Lancet"},{"key":"R41-1-20210131","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1128\/JVI.72.6.5099-5107.1998","article-title":"Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.","volume":"72","author":"van t Wout","year":"1998","journal-title":"J Virol"},{"key":"R42-1-20210131","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1128\/JVI.79.14.9006-9018.2005","article-title":"Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.","volume":"79","author":"Troyer","year":"2005","journal-title":"J Virol"},{"key":"R43-1-20210131","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1086\/315339","article-title":"Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.","volume":"181","author":"Lyles","year":"2000","journal-title":"J Infect Dis"},{"key":"R44-1-20210131","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0042-6822(92)90593-E","article-title":"Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.","volume":"189","author":"Layne","year":"1992","journal-title":"Virology"},{"key":"R45-1-20210131","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/JVI.01739-06","article-title":"Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection.","volume":"81","author":"Mehandru","year":"2007","journal-title":"J Virol"},{"key":"R46-1-20210131","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/516537","article-title":"In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication.","volume":"176","author":"Pal","year":"1997","journal-title":"J Infect Dis"},{"key":"R47-1-20210131","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.96.2.663","article-title":"CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.","volume":"96","author":"Penn","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R48-1-20210131","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1128\/JVI.68.12.8188-8192.1994","article-title":"Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.","volume":"68","author":"Kaneshima","year":"1994","journal-title":"J Virol"},{"key":"R49-1-20210131","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/JVI.74.7.3196-3204.2000","article-title":"Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication.","volume":"74","author":"Camerini","year":"2000","journal-title":"J Virol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200808150-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:49:38Z","timestamp":1786038578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200808150-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,15]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31817ecb31","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8,15]]}}}